Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSherief Abd-Elsalam
About this trial
Clinical and Economic study of some new biomarkers in chronic heart failure.
Eligibility criteria
Qualifiers
NYHA-Class II-IV
Disqualifiers
Liver or renal dysfunction. --DM
Trial design
Treatments tested in this trial
- New york Heart Association Class II-IV
- New york Heart Association Class I
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov